ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+5.35%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$235M
AUM Growth
+$46.1M
(+24%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
46.57%
Holding
91
New
39
Increased
11
Reduced
15
Closed
22
Top Buys
| 1 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$12.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11.5M |
| 3 |
Gilead Sciences
GILD
|
$10.1M |
| 4 |
Takeda Pharmaceutical
TAK
|
$8.91M |
| 5 |
Icon
ICLR
|
$8.16M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$14.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.8M |
| 3 |
SHPG
Shire pic
SHPG
|
$8.02M |
| 4 |
CVS Health
CVS
|
$7.36M |
| 5 |
DaVita
DVA
|
$7.24M |
Sector Composition
| 1 | Healthcare | 79.87% |
| 2 | Technology | 11.14% |
| 3 | Industrials | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTGN
26
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $2.75M | 1.09% |
+425,291
| New | +$2.75M |
|
27
Liquidia Corp
LQDA
$2.51B
| $2.68M | 1.06% |
235,329
+196,190
| +501% | +$2.23M |
|
|
AGN
28
DELISTED
Allergan plc
AGN
| $2.67M | 1.06% |
18,263
-100,808
| -85% | -$14.8M |
|
29
Elevance Health
ELV
$70.5B
| $2.61M | 1.03% |
+9,084
| New | +$2.61M |
|
30
Bausch Health
BHC
$2.72B
| $2.58M | 1.02% |
104,344
-59,564
| -36% | -$1.47M |
|
31
Vericel Corp
VCEL
$1.73B
| $2.16M | 0.85% |
+123,111
| New | +$2.16M |
|
|
XENT
32
DELISTED
Intersect ENT, Inc
XENT
| $2.11M | 0.83% |
+65,557
| New | +$2.11M |
|
33
Krystal Biotech
KRYS
$4.38B
| $2.01M | 0.8% |
61,155
+48,655
| +389% | +$1.6M |
|
|
SIOX
34
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.93M | 0.76% |
+181,664
| New | +$1.93M |
|
35
Abbott
ABT
$232B
| $1.92M | 0.76% |
+23,966
| New | +$1.92M |
|
36
Align Technology
ALGN
$10B
| $1.86M | 0.74% |
+6,557
| New | +$1.86M |
|
|
MRNS
37
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.83M | 0.72% |
+109,325
| New | +$1.83M |
|
38
Viking Therapeutics
VKTX
$2.99B
| $1.77M | 0.7% |
178,448
+124,982
| +234% | +$1.24M |
|
|
OXFD
39
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.77M | 0.7% |
102,593
-358,641
| -78% | -$6.18M |
|
40
AbbVie
ABBV
$374B
| $1.75M | 0.69% |
+21,674
| New | +$1.75M |
|
41
Sarepta Therapeutics
SRPT
$1.96B
| $1.71M | 0.68% |
14,364
-7,251
| -34% | -$864K |
|
42
Dentsply Sirona
XRAY
$2.92B
| $1.44M | 0.57% |
28,988
-89,436
| -76% | -$4.44M |
|
|
TVTY
43
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.37M | 0.54% |
+77,929
| New | +$1.37M |
|
44
Agilent Technologies
A
$36.5B
| $1.01M | 0.4% |
+12,583
| New | +$1.01M |
|
|
RVLP
45
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $1.01M | 0.4% |
279,561
+47,513
| +20% | +$171K |
|
46
Molina Healthcare
MOH
$9.42B
| $828K | 0.33% |
+5,830
| New | +$828K |
|
|
SIEN
47
DELISTED
Sientra, Inc.
SIEN
| $758K | 0.3% |
+8,837
| New | +$758K |
|
48
Axsome Therapeutics
AXSM
$6.23B
| $744K | 0.29% |
52,268
-156,927
| -75% | -$2.23M |
|
49
Teladoc Health
TDOC
$1.38B
| $731K | 0.29% |
+13,153
| New | +$731K |
|
|
VRAY
50
DELISTED
ViewRay, Inc.
VRAY
| $714K | 0.28% |
+96,580
| New | +$714K |
|